Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

被引：0
|
作者：
Pinto, L. C. [1 ]
Rados, D. R. [1 ]
Retnonti, L. R. [1 ]
Viana, M. V. [1 ]
Leitao, C. B. [1 ]
Gross, J. L. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Endocrine Div, Porto Alegre, RS, Brazil
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [41] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Shi-di Zhao
    Ling Zhou
    Yi-ying Tao
    Yue Yue
    Jia-xin Wang
    Lei Shen
    Guo-yuan Lu
    Yong-fu Hang
    International Journal of Diabetes in Developing Countries, 2022, 42 : 178 - 190
  • [42] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Zhao, Shi-di
    Zhou, Ling
    Tao, Yi-ying
    Yue, Yue
    Wang, Jia-xin
    Shen, Lei
    Lu, Guo-yuan
    Hang, Yong-fu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 178 - 190
  • [43] Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta-analysis
    Li, Xiaoyu
    Li, Ting
    Cheng, Ying
    Lu, Yunhong
    Xue, Mei
    Xu, Linxin
    Liu, Xiangyang
    Yu, Xiaochen
    Sun, Bei
    Chen, Liming
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (07)
  • [44] Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Milder, Tamara Y.
    Stocker, Sophie L.
    Shaheed, Christina Abdel
    McGrath-Cadell, Lucy
    Samocha-Bonet, Dorit
    Greenfield, Jerry R.
    Day, Richard O.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [45] Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes A meta-analysis with trial sequential analysis
    Qiu, Mei
    Ding, Liangliang
    Zhou, Hairong
    MEDICINE, 2021, 100 (10) : E25121
  • [46] Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Sayour, Alex Ali
    Olah, Attila
    Ruppert, Mihaly
    Barta, Balint Andras
    Merkely, Bela
    Radovits, Tamas
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [47] Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Alex Ali Sayour
    Attila Oláh
    Mihály Ruppert
    Bálint András Barta
    Béla Merkely
    Tamás Radovits
    Scientific Reports, 14
  • [48] The Impact of SGLT2 Inhibitors on Dementia Onset in Patients with Type 2 Diabetes: A Meta-Analysis of Cohort Studies
    Pan, Jiani
    Yang, Huiping
    Lu, Jiatong
    Chen, Ling
    Wen, Tian
    Zhao, Shijie
    Shi, Liye
    NEUROENDOCRINOLOGY, 2025,
  • [49] Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis
    Mainak Banerjee
    Rimesh Pal
    Satinath Mukhopadhyay
    Acta Diabetologica, 2022, 59 : 783 - 791
  • [50] Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis
    Butler, Javed
    Usman, Muhammad Shariq
    Khan, Muhammad Shahzeb
    Greene, Stephen J.
    Friede, Tim
    Vaduganathan, Muthiah
    Filippatos, Gerasimos
    Coats, Andrew J. Stewart
    Anker, Stefan D.
    ESC HEART FAILURE, 2020, 7 (06): : 3298 - 3309
12345